アセチルコリンアナログは,特定のマスカリン受容体亜型を通じて,脳由来細胞におけるDNA合成を刺激する
A Ashkenazi1, J Ramachandran, D J Capon
1Department of Molecular Biology, Genentech, Incorporated, South San Francisco, California 94080.
Nature
|July 13, 1989
まとめ
アセチルコリンは,マスカリン酸アセチルコリン受容体 (mAChRs) を通して,発達中の脳膠質細胞におけるDNA合成を刺激する. 受容体のサブタイプの発現が増殖反応を決定し,アセチルコリンの重要な役割が,アストログリアル細胞の成長調節にあることを示唆している.
科学分野:
- 神経科学は神経科学である.
- 細胞生物学 細胞生物学
- 発達生物学 発達生物学とは
背景:
- 神経細胞の増殖は哺乳類の脳の発達初期に停止する.
- 膠質細胞の増殖と分化は,主に生理周期の間に起こります.
- アセチルコリンシグナル伝達,特にフォスホイノシチド (PI) 水解は,胎児期の脳でピークに達する.
研究 の 目的:
- アセチルコリンのアナログであるカルバコールが,胎児期の脳細胞における細胞DNA合成を誘発できるかどうかを調査する.
- カルバコール誘発細胞増殖を媒介するマスカリン酸アセチルコリン受容体 (mAChRs) の役割を決定する.
- mAChRサブタイプの発現がアセチルコリンに対する増殖反応にどのように影響するか調べる.
主な方法:
- 周期のラット脳から採取した一次性アストロサイトは,カルバコールで治療した.
- DNA合成に対するカルバコール効果は,様々な脳由来細胞系と,再結合mAChRsを発現する中国ハムスター卵巣 (CHO) 細胞で評価された.
- mAChRサブタイプ発現,PI水解活性化,DNA合成の相関性を分析した.
主要な成果:
- カーバコレンは,年齢に依存した方法で,プライマリア・アストロサイトにおけるDNA合成を著しく刺激した.
- カーバホルは,アストロサイトマ,ニューロブラストマ細胞系,およびmAChRsを発現するCHO細胞にミトジェニック効果を示した.
- 細胞増殖は,PI水解を活性化する mAChRサブタイプの効率と相関する.
結論:
- アセチルコリンは,脳の発達中のアストログリアル細胞の成長を調節する上で重要な役割を果たします.
- アセチルコリン誘発細胞増殖の特異性は,PI水解を活性化する特定のmAChRサブタイプの発現によって決定されます.
- この研究は,哺乳類の発達中の脳における膠質細胞の増殖を調節する新しいシグナル伝達経路を強調しています.
さらに関連する動画
関連する概念動画
01:25Cholinergic Receptors: Muscarinic
The pharmacological actions of acetylcholine are elicited via its binding to two families of cholinergic receptors or cholinoceptors, namely, muscarinic and nicotinic receptors. Muscarinic receptors are G protein-coupled receptors and have five subtypes, M1–M5. All mAChR subtypes are activated by acetylcholine and blocked by the antagonist, atropine.
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+. Activation...
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+. Activation...
01:22Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
The direct-acting...
01:31Direct-Acting Cholinergic Agonists: Pharmacokinetics
Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
00:59Direct-Acting Cholinergic Agonists: Pharmacological Actions
Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
01:11Direct-Acting Cholinergic Agonists: Therapeutic Uses
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren syndrome.
01:30Indirect-Acting Cholinergic Agonists: Pharmacological Actions
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...